Illumina Ventures Announces Strategic New Additions to its Investment Team

Rhea-AI Summary

Illumina Ventures announced the addition of two key members to its investment team: Abhijit “Ron” Mazumder as Partner and Lisa Alderson as Entrepreneur in Residence. Ron Mazumder brings nearly 30 years of experience in biomarkers and diagnostics from his previous roles at Genentech, Johnson & Johnson, and Merck. Lisa Alderson has over 25 years of experience in tech and healthcare, co-founding Genome Medical and holding executive positions at Invitae. These appointments aim to enhance the firm's ability to support innovation in genomics and precision medicine.

Positive

• Ron Mazumder's extensive experience in biomarkers and diagnostics strengthens the investment team's expertise.
• Lisa Alderson's background in scaling genomics-based businesses will likely benefit Illumina Ventures' growth.

Negative

• None.

Abhijit “Ron” Mazumder joins as Partner

Lisa Alderson joins as Entrepreneur in Residence

​FOSTER CITY, Calif.--(BUSINESS WIRE)-- Illumina Ventures, a genomics and precision health focused venture firm, today announced additions to its investment team. Abhijit “Ron” Mazumder, PhD, MBA, joins as a Partner and Lisa Alderson, MBA as an Entrepreneur in Residence.

Ron brings almost thirty years of experience working with biomarkers, technologies, and computational approaches for pharmaceutical and diagnostics programs. After leading the development of genomics technologies and novel platforms for several biotech companies, Ron worked for Johnson and Johnson and Merck, where he developed diagnostics and companion diagnostics, pharmacodynamic and predictive biomarkers. Most recently, Ron was Vice President and Global Head of Oncology Biomarker Development and Companion Diagnostics at Genentech.

“We are fortunate to expand our bench of talent with the addition of Lisa and Ron,” said Nick Naclerio, PhD, Illumina Ventures Founding Partner. “These two new members will bring a wealth of knowledge and experience to help us continue to support innovation in genomics and precision medicine.”

Lisa has more than twenty-five years of experience creating and scaling innovative, high-growth businesses at the intersection of technology and healthcare with a focus on genomics, digital health, SaaS, telehealth, and molecular diagnostics. She is a mission-driven founder, board member, and advisor dedicated to improving patient care and advancing the adoption of precision medicine. Lisa co-founded and served as CEO of Genome Medical, the leading telehealth provider of genomics-based care to patients nationwide. She also served as Chief Commercial Officer and Chief Strategy Officer at Invitae, a genetic information and molecular diagnostics company, where she led the commercial organization through initial commercial launch, scale-up, and IPO.

​About Illumina Ventures Illumina Ventures is an independently managed, healthcare-focused venture firm in a strategic partnership with Illumina (NASDAQ: ILMN). As an early-stage, value-add investor, Illumina Ventures helps entrepreneurs develop breakthrough science and technologies into market-leading companies to transform healthcare. The firm focuses on investment in life science tools, therapeutics, diagnostics, and personal wellness. To learn more, visit illuminaventures.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20230124005209/en/

Valerie Enes, Vice President, Seismic

408-497-8568

valerie@teamseismic.com

Source: Illumina Ventures

FAQ

Who are the new team members at Illumina Ventures?

The new team members are Abhijit 'Ron' Mazumder as Partner and Lisa Alderson as Entrepreneur in Residence.

What is Abhijit Mazumder's background?

Abhijit Mazumder has nearly 30 years of experience in biomarkers and diagnostics, previously working at Genentech, Johnson & Johnson, and Merck.

What experience does Lisa Alderson bring to Illumina Ventures?

Lisa Alderson has over 25 years of experience in technology and healthcare, co-founding Genome Medical and serving in executive roles at Invitae.

What is the focus of Illumina Ventures?

Illumina Ventures focuses on investing in life science tools, therapeutics, diagnostics, and personal wellness, particularly in genomics and precision medicine.

What is Illumina Ventures' partnership with Illumina?

Illumina Ventures is an independently managed venture firm in a strategic partnership with Illumina.